Skip to content

A Retrospective Database Study for the Development and Validation of Algorithms for Intracerebral Hemorrhage and Seizures in Alzheimer's Disease

Development and Validation of Algorithms for Identifying Intracerebral Hemorrhage and Seizures in Patients With Alzheimer's Disease: A Retrospective Database Study Using United States Healthcare Administrative Claims Data

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07723950
Enrollment
600
Registered
2026-07-23
Start date
2026-07-30
Completion date
2026-12-31
Last updated
2026-07-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer's Disease

Keywords

Alzheimer's Disease, Intracerebral Hemorrhage, Seizures, US Healthcare Claims Data

Brief summary

The primary objective of this study is to develop and validate claims-based algorithms to identify intracerebral hemorrhage \>1 cm in diameter, ensuring differentiation from amyloid-related imaging abnormality-microhemorrhage and hemosiderin deposit (ARIA-H; microhemorrhage, superficial siderosis) in participants with Alzheimer's disease (AD) using claims data in the United States (US) with linkage to electronic health records (EHRs), and to estimate the positive predictive values (PPVs) of the algorithms. The secondary objective of the study is to validate claims-based algorithms to identify new-onset seizures in participants with AD using US claims data with linkage to EHRs and to estimate the PPVs of the algorithms.

Detailed description

As this is a Retrospective Database Study, the Study Start Date for this study references the date at which the first set of data will become available.

Interventions

OTHERNo intervention

This is a non-interventional study.

Sponsors

Eisai Inc.
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Before or on the outcome event date, have at least 1 ICD-10-CM diagnosis code for AD in medical claims in an inpatient setting; or have at least 2 ICD-10-CM diagnosis codes in medical claims in an outpatient setting, at least 7 days and less than 365 days apart * Have at least 365 days of continuous coverage with medical and pharmacy benefits before the outcome event date * Have EHR data available for (1) the outcome event date or (2) during the period of up to 30 days before and up to 90 days after the outcome event date * Have unstructured EHR information (ie, clinical notes) available for any encounter (1) on the outcome event date or (2) during the period of 30 days before to up to 45 days after the outcome event date

Exclusion criteria

* New-onset seizure outcome only: Have any ICD-10-CM diagnosis code for seizure or epilepsy before the outcome event date

Design outcomes

Primary

MeasureTime frame
Positive Predictive Value (PPV) of algorithms to identify intracerebral hemorrhage >1 cm in diameterUp to 9.5 years

Secondary

MeasureTime frame
PPV of algorithms to identify new-onset seizureUp to 9.5 years

Contacts

CONTACTEisai Medical Information
esi_medinfo@eisai.com+1-888-274-2378

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 24, 2026